Insider Transactions in Q4 2021 at Globe Life Inc. (GL)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Steven John Dichiaro |
SELL
Open market or private sale
|
Direct |
700
-8.05%
|
$65,800
$94.52 P/Share
|
|
Dec 23
2021
|
Robert W Ingram Director |
SELL
Open market or private sale
|
Direct |
219
-0.71%
|
$20,148
$92.65 P/Share
|
|
Dec 22
2021
|
Gary L Coleman Co-Chairman |
SELL
Bona fide gift
|
Direct |
13,200
-2.08%
|
-
|
|
Dec 21
2021
|
Melissa Jane Buchan Director |
SELL
Bona fide gift
|
Direct |
570
-0.7%
|
-
|
|
Dec 20
2021
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
7,300
-60.83%
|
$620,500
$85.68 P/Share
|
|
Dec 20
2021
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+38.64%
|
$480,000
$40.51 P/Share
|
|
Dec 16
2021
|
Steven John Dichiaro |
SELL
Open market or private sale
|
Direct |
1,400
-13.86%
|
$130,200
$93.0 P/Share
|
|
Dec 06
2021
|
Steven John Dichiaro |
SELL
Open market or private sale
|
Direct |
873
-7.96%
|
$79,443
$91.05 P/Share
|
|
Dec 01
2021
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Bona fide gift
|
Indirect |
335
+33.67%
|
-
|
|
Dec 01
2021
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Bona fide gift
|
Indirect |
670
-1.27%
|
-
|
|
Nov 17
2021
|
Charles E Adair Director |
SELL
Open market or private sale
|
Direct |
1,667
-17.8%
|
$155,031
$93.98 P/Share
|
|
Nov 17
2021
|
Charles E Adair Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+15.11%
|
$90,018
$54.16 P/Share
|
|
Nov 04
2021
|
Mark A Blinn Director |
BUY
Grant, award, or other acquisition
|
Direct |
289
+50.0%
|
-
|
|
Nov 04
2021
|
James Brannen Director |
BUY
Grant, award, or other acquisition
|
Direct |
289
+50.0%
|
-
|
|
Nov 02
2021
|
Melissa Jane Buchan Director |
SELL
Open market or private sale
|
Direct |
1,700
-2.05%
|
$156,400
$92.08 P/Share
|